|3 Months Ended|
Mar. 31, 2020
|Stockholders' Equity Note [Abstract]|
NOTE 9 STOCKHOLDERS DEFICIT
During the three months ended March 31, 2020, no shares were issued. The Company received $416,667 from investors in exchange for 4,166,667 restricted common shares, par value $.001 per share, for $0.10 per share and 4,000,000 five-year warrants with a strike price of $0.30 per share and 16,667 five-year warrants with a strike price of $0.40 per share. The $416,667 is reflected as a subscription liability on the Companys condensed consolidated balance sheet as of March 31, 2020. The shares were subsequently issued to investors on April 1, 2020 and April 13, 2020 as discussed in Note 12.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef